首页> 外文期刊>Journal of Surgical Oncology >Outcomes of surgery aiming at curative resection in good responder to induction chemotherapy for gastric cancer with distant metastases
【24h】

Outcomes of surgery aiming at curative resection in good responder to induction chemotherapy for gastric cancer with distant metastases

机译:以远期转移性胃癌为目标,对诱导化疗有良好反应的以手术切除为目标的手术结果

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Background The aim of this study is to analyze the outcome of surgery with curative intent in good responder to induction chemotherapy for gastric cancer with distant metastases (M1 gastric cancer). Materials and Methods We reviewed M1 gastric cancer patients in whom radiologic evaluation suggests disappearance of metastatic lesion after chemotherapy and received operation from January 2000 to December 2009. Clinicopathologic variables and oncologic outcomes were evaluated. Results Of the 34 patients who underwent surgery with curative intent after chemotherapy, overall R0 resection rate was 76.5% (26/34). R0 resection rate was 88.0% (22/25) in initial one metastatic site and 44.4% (4/9) in two metastatic sites (P = 0.017). Postoperative morbidity and mortality rate were 14.7% and 0%. Recurrence rate was 61.5% (16/26) after R0 resection. Median survival was 22.9 and 7.8 months according to R0 versus non-R0 resection (P = 0.033). After R0 resection, 3-year overall survival was 51.7% in ypN0-2 stage group. Conclusion The present study provides evidence that in patients with M1 gastric cancer which confined to one site who respond well to induction chemotherapy, a higher rate of R0 resection and longer survival can be expected. A multicenter cohort study is needed to explore this concept further.
机译:背景技术这项研究的目的是分析对远距离转移性胃癌(M1胃癌)诱导化疗有良好反应的治愈性手术结果。材料和方法我们回顾了2000年1月至2009年12月接受放射治疗后化疗后转移灶消失的M1胃癌患者,并对其手术进行了评估。对临床病理变量和肿瘤学结局进行了评估。结果34例经化疗治愈的患者中,R0切除率为76.5%(26/34)。最初的一个转移部位的R0切除率为88.0%(22/25),而在两个转移部位的R0切除率为44.4%(4/9)(P = 0.017)。术后发病率和死亡率分别为14.7%和0%。 R0切除后的复发率为61.5%(16/26)。根据R0对比非R0切除,中位生存期分别为22.9和7.8个月(P = 0.033)。 R0切除后,ypN0-2分期组的3年总生存率为51.7%。结论本研究提供了证据,在局限于一个部位且对诱导化疗反应良好的M1型胃癌患者中,可以预期更高的R0切除率和更长的生存期。需要进行多中心队列研究以进一步探索该概念。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号